thiazolyl blue has been researched along with Thrombocytopenia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aramori, I; Fujimura, T; Matsuoka, H; Mori, H; Mutoh, S; Noto, T; Takata, Y; Unami, A; Yamada, T; Yoshizawa, K | 1 |
1 other study(ies) available for thiazolyl blue and Thrombocytopenia
| Article | Year |
|---|---|
Novel method for selecting immunosuppressive histone deacetylase (HDAC) inhibitors with minimal thrombocytopenia.
Topics: Animals; Cell Survival; Drug Evaluation, Preclinical; Enzyme Inhibitors; GATA1 Transcription Factor; Genes, Reporter; Heart Transplantation; Histone Deacetylase Inhibitors; Humans; Immunosuppressive Agents; Interleukin-2; Jurkat Cells; Male; Plasmids; Rats; Rats, Inbred Lew; Reverse Transcriptase Polymerase Chain Reaction; Structure-Activity Relationship; Tetrazolium Salts; Thiazoles; Thrombocytopenia; Transplantation, Heterotopic | 2008 |